ALB and metabolic dysfunction-associated steatohepatitis: To investigate potential interactions between hepatic CCN2 and NASH pathways, we compared liver pathology in WT versus Alb-CCN2 TG Balb/c mice maintained on a control or CDAA-HF diet.